CN Patent
CN113453723A — 接头
Assigned to Oxford University Innovation Ltd · Expires 2021-09-28 · 5y expired
What this patent protects
本发明涉及用于将载体分子连接到治疗分子以形成缀合物的接头,特别是由氨基酸例如谷氨酸、琥珀酸和γ‑氨基丁酸形成的接头。本发明还涉及包含本发明接头的缀合物,以及所述缀合物在治疗多种疾病中的用途。
USPTO Abstract
本发明涉及用于将载体分子连接到治疗分子以形成缀合物的接头,特别是由氨基酸例如谷氨酸、琥珀酸和γ‑氨基丁酸形成的接头。本发明还涉及包含本发明接头的缀合物,以及所述缀合物在治疗多种疾病中的用途。
Drugs covered by this patent
- Amondys 45 (CASIMERSEN) · Sarepta
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.